Purpose: The pharmacology, pharmacokinetics, drug interactions, clinical efficacy, adverse effects, monitoring, and dosage and administration of enteric-coated (EC) mycophenolate sodium are reviewed.
The optimum treatment for patients with membranous lupus nephritis is uncertain. Several therapeutic regimens have been suggested, including corticosteroids plus cyclophosphamide or chlorambucil; ...
Review the side-effects of Mycophenolate Mofetil as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In ...
Please provide your email address to receive an email when new articles are posted on . Early mycophenolate mofetil in newly diagnosed SLE led to fewer severe flares and lower incidence of lupus ...
The product is bioequivalent and therapeutically equivalent to the reference listed drug (RLD), CellCept for oral suspension, 200 mg/m; of Roche Palo Alto, LLC, it added. The approval bolsters the ...
Substantial evidence exists that patients with scleroderma have immune dysfunction and autoimmunity, and several studies support the use of immunosuppressive treatment in these patients. Nihtyanova et ...
Researchers reported today that patients treated with CellCept® (mycophenolate mofetil), a drug used to prevent rejection in organ transplantation, have significantly lower progression of intimal ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Mycophenolate mofetil was superior to azathioprine in ...
CellCept (mycophenolate mofetil) is not safe to take while pregnant or breastfeeding. Certain factors, including the risks of fetal harm and pregnancy loss, may determine whether you should take the ...
The addition of mycophenolate mofetil (MMF) to a glucocorticoid as a first-line treatment for immune thrombocytopenia (ITP) resulted in greater responses and a reduced risk of relapse or refractory ...
Global Mycophenolate Mofetil Market Trends That Will Drive Success in 2020 | Genentech, Teva, Sandoz
The ‘Mycophenolate Mofetil Market study‘ 2020 offers an in-depth analysis pertaining to potential drivers fueling this industry. The study also elucidates valuable insights about profitability ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results